Tune in as Dr. Martin Kolb, speaks to patients and caregivers about progressing fibrosis interstitial lung diseases. In this CPFF Educational Session, Dr. Kolb explains interstitial lung diseases (non-fibrotic, fibrotic, progressive fibrotic – prototype IPF), diagnosis (splitting vs. Lumping), and management of progressive fibrotic ILD.
Dr. Martin Kolb is the Moran Campbell Chair and Professor in Respiratory Medicine and Director of the Division of Respirology, McMaster University, Hamilton, Ontario, Canada. His major research interests are fibrotic lung disease, with a particular interest in the role of growth factors and matrix abnormalities in disease progression. He leads activities in biomarker development for lung fibrosis, and is a Principal Investigator and steering committee member in numerous ILD clinical trials. Professor Kolb has authored over 130 peer-reviewed publications on different basic science and clinical topics. He is the Chief-Editor of the European Respiratory Journal (2018-2023). He is also an editorial board member of American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory Cell and Molecular Biology, the European Respiratory Review and Respirology, and serves on the Lung Injury & Repair Study Section for the National Institute of Health.